Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature

American Journal of Hematology

Volumn 63, Issue 1, 2000, Pages 46-53

  Cooley, Linda D ^a   Sears, David A ^b,c   Udder, Mark M ^b   Harrison, Wilbur R ^a   Baker, Kelty R ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; Leukemia; Recurrence

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; METHOTREXATE; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHROMOSOME 10; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LEUKEMIA; MALE; PRIORITY JOURNAL; TANDEM REPEAT;

ADULT; BONE MARROW TRANSPLANTATION; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; TANDEM REPEAT SEQUENCES; TIME FACTORS; TISSUE DONORS; TRANSLOCATION, GENETIC;

EID: 0033985765     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(200001)63:1<46::AID-AJH11>3.0.CO;2-F     Document Type: Article

References (55)

1. Deeg HJ, Sanders J, Martin P, Fefer A, Neiman P, Singer J, Storb R, Thomas ED. Secondary malignancies after marrow transplantation. Exp Hematol 1984;12:660-666.
2. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg J, Doney K, Thomas D, Storb R, Thomas ED. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. New Eng J Med 1989;321:784-789.
3. Lowsky R, Lipton J, Fyles G, Minden M, Meharchand J, Tejpar I, Atkins H, Sutcliffe S, Messner H. Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 1994;12:2187-2192.
4. Witherspoon RP, Deeg HJ, Storb R. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia. Transplantation 1994;7:1413-1418.
5. Bhatia S, Ramsay NKC, Steinbuch M, Dusenberg KE, Shapiro RS, Weisdorf DJ, Robeson LL, Miller JS, Negla JP. Malignant neoplasms following bone marrow transplantation. Blood 1996;87:3633-3639.
6. Curtis RE, Rowlings PA, Deeg J, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF, Boice JD Jr. Solid cancers after bone marrow transplantation. New Eng J Med 1997;336:897-904.
7. Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF, Weiss M, Cohen A, Nekolla E, Kolb, H-J. Health and functional status of long-term survivors of bone marrow transplantation. Ann Intern Med 1997;126:184-192.
8. Deeg JH. Delayed complications after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. Boston: Blackwell Scientific Publications; 1994. Chap 39, p 538.
9. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994;84:3603-3612.
10. Boyd CN, Ramberg RC, Thomas ED. The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res 1982;6:833-837.
11. ISCN 1995: International System for Human Cytogenetic Nomenclature. Mitelan F, editor. Basel: S. Karger; 1995.
12. Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M. Hereditary multiple exostosis and chrondrosarcoma: linkage to chromosome 11 and loss of heterozygosity for EXT-linked markers on chromosomes 11 and 8. Am J Hum Genet 1995;56:1125-1131.
13. Fialkow PJ, Thomas ED, Bryant JI, Neiman PE. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971;1:251-255.
14. Groupe Francais de Cytogenetique Hematologique. Acute myelogenous leukemia with an 8:21 translocation. A report on 148 cases from the Groupe Francais de Cytogenetique Hematologique. Cancer Genet Cytogenet 1990;44:169-179.
15. Thomas ED, Bryant JI, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman P, Ramberg RE, Storb R. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1972;1:1310-1313.
16. Goh, K-O, Klemperer MR. In vivo leukemic transformation: cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells. Am J Hematol 1977;2:283-290.
17. Elfenbein GJ, Brogaonkar DS, Bias WB, Burns WH, Saral R, Sensenbrenner LL, Tutschka PJ, Zaczek BS, Zander AR, Epstein RB, Rowley JD, Santos GW. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood 1978;52:627-635.
18. Newburger PE, Latt SA, Pesando JM, Gustashaw K, Powers M, Chaganti RSK, O'Reilly RJ. Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. New Eng J Med 1981;304:712-714.
19. 1-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. New Eng J Med 1984;310:903-906.
20. Witherspoon RP, Schubach W, Neiman P, Martin P, Thomas ED. Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood 1985;65:1172-1174.
21. Smith JL, Heerema NA, Provisor AJ. Leukaemic transformation of engrafted bone marrow cells. Brit J Haematol 1985;60:415-422.
22. Palka G, Di Bartolomeo P, Iacone A, Di Girolamo G. Betti S, Calabrese G, Natale D, Stuppia L, Rieve AK, Torlontano G. Cytogenetics and bone marrow transplantation. Cancer Genet Cytogenet 1986;21: 147-157.
23. Zaccaria A, Rosti G, Testoni N, Arnold R, Bandini G, Becher R, Boogaerts M, Carbonell F, Di Bartolomeo P, Gerrant A, Filippetti A. Frassoni F, Gahrton G, Haas OA, Mecucci C, Michaux J-L, Palka G, Pollak C, Ricci P, Rosetti A, Sessarego M, Valenti S, Van den Berghe H, Tura, S. Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation - results of a European cooperative study. Cancer Genet Cytogenet 1987;26:51-58.
24. Schmitz N, Johanason W, Schmidt G, von der Helm K, Loffler H. Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood 1987;70:1099-1104.
25. Feig SA, Dreazen O, Simon M, Wiley F, Schreck R, Gale RP. B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL. Bone Marrow Transplantation 1988;3:331-337.
26. Palka G, Calabrese G, Di Girolamo G, Stuppia L, Di Barolomeo P. Franchi PG, Di Birgilio C, Bianchi GP, Angrilli F, Parruti, G. Torlontano G. Cytogenetic survey of 31 patients treated with bone marrow transplantation for acute nonlymphocytic and acute lymphoblastic leukemias. Caner Genet Cytogenet 1991;51:223-233.
27. Browne PV, Lawler M, Humphries PM, McCann SR. Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. New Eng J Med 1991;325:710-713.
28. Cullis JO, Marks DI, Schwarer AP, Barren AJ, Hows JM, Swirsky DM, Goldman JM. Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases. Brit J Haematol 1992;81:378-382.
29. McCann SR, Lawler M, Humphries P, Bacigalupo A, Podesta M, Frassoni F, Van Lint MT, Marmont A. Recurrence of Philadelphia chromosome-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia: confirmation by microsatellite studies (letter). Blood 1992;79:2803-2805.
30. Katz F, Reeves BR, Alexander S, Kearney L, Chessells J. Leukaemia arising in donor cells following allogeneic bone marrow transplantation for thalassaemia demonstrated by immunological. DNA and molecular cytogenetic analysis. Brit J Haematol 1993;85:326-331.
31. McCann, Lawler M, Bacigalupo A. Recurrence of Philadelphia chromosome-positive leukemia in donor cells utter bone marrow transplantation for chronic granulocytic leukemia. Leukemia Lymphoma 1993; 10:419-425.
32. Mouratidou M, Sotiropoulos D, Deremitzaki K, Spathas DH, Hoffbrand AV, Prentice HG, Papanastasiou K, Tsakanikas S, Tsaftaridis P, Stamatelou M, Maniatis A. Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization. Bone Marrow Transplant 1993;12:77-80.
33. Cransac M, Boiron J-M, Merel P, Cony-Makhoul P, Marit G, Bernard P, Ferber J, Reiffers J. Burkitt-type acute lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia. Transplantation 1993;56:120-123.
34. Fyles GM, Minden MD, Meharchand JM, Lipton JH, Atkins HL, Tejpar I, Messner HA. Donor cell derived acute myelogenous leukemia (AML) developing post allogeneic bone marrow transplant (BMT) for a patient with chronic myelogenous leukemia (CML). J Cell Biochem 1994;18B(suppl):63 (abstr).
35. Lowsky R, Fyles G, Minden M, Lipton J. Meharchand J, Tejpar I, Zipursky A, Messner H. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Brit J Haematol 1996;93:163-165.
36. Anastasi J, Thangavelu M, Vardiman JW, Hooberman AL, Bian ML, Larson RA, LeBeau MM. Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphocytic leukemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation. Blood 1991;77:1087-1091.
37. Biondi A, Norman C, Messner HA, Minden MD. Restriction fragment length polymorphism analysis of hematopoietic cells following successful treatment of relapsed acute lymphoblastic leukemia following bone marrow transplantation. Bone Marrow Transplant 1989;4:705-709.
38. Perla G, Bodenizza C, Falcone A, Melillo L, Scolaro E, Carotenuto M, Musto P. Misleading cytogenetic evidence of relapse in donor cells after allogeneic bone marrow transplantation corrected by fluorescent in situ hybridization. Haematologica (Pavia) 1995;80:292-293.
39. Stein J, Zimmerman PA, Kochera M, Strandjord S, Golden W, Simon M, Warkentin P, Blazar BR, Coccia P, Lang-Unnasch N. Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses. Blood 1989; 73:2033-2040.
40. Naoe T, Kiyoi H, Yamanaka K, Naito K, Yamada K. A case of cALL relapse after allogeneic BMT: recurrence of recipient cell origin, initially determined as being that of donor cell origin by sex chromosome analysis. Brit J Haematol 1989;73:420-422.
41. Chalmers EA, Sproul AM, Mills Kl, Burnett AK. Cytogenetic and molecular analysis of relapse following bone marrow transplantation (letter). Br J Haematol 1990;75:631-632.
42. Minden MD, Messner HA, Belch A. Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism. J Clin Invest 1985;75:91-93.
43. Blazar BR, Orr HT, Arthur DC, Kersey JH, Filipovich, AH. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 1985;66:1436-1444.
44. Ginsburg D, Antin JH, Smith BR, Orkin SH, Rappeport JM. Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms. J Clin Invest 1985;75:596-603.
45. Knowlton RG, Brown VA, Braman JC, Barker D, Schumm JW, Murray C, Takvorian T, Ritz J, Donis-Keller H. Use of highly polymorphic probes for genotypic analysis following bone marrow transplantation. Blood 1986;68:378-385.
46. Yam PY, Petz LD, Knowlton RG, Wallace RB, Stock AD, de Lange G, Brown VA, Donis-Keller H, Blume KG. Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 1987;43:399-407.
47. Ganesan TS, Min GL, Goldman JM, Young BD. Molecular analysis of relapse in chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood 1987;70:873-876.
48. Min GS, Hibbin J, Arthur C, Apperley J, Jeffreys A, Goldman J. Use of minisatellite DNA probes for recognition and characterization of relapse after allogeneic bone marrow transplantation. Br J Haematol 1988;68:195-201.
49. Fyles GM, Messner HA, Lockwood G, Curtis JE, Rider W, Minden MD, Meharchand JM, Lipton J, Tritchler D, Van Dyk J, Keane T, Sutcliffe S. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate. Bone Marrow Transplant 1991;8:453-463.
50. Niederwieser DW, Appelbaum FR, Gastl G, Gersdorf E, Meister B, Geissler D, Tratkiewic; JA, Thaler J, Huber C. Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. New Eng J Med 1990;322: 1794-1796.
51. Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998;91:1833-1844.
52. Rustin GJS, Rustin F, Dent J, Booth M, Salt S, Bagshawe KD. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors. New Eng J Med 1983;308:473-476.
53. Bertino JR, Romanini A. Chemotherapeutic agents. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR, editors. Cancer medicine, 3rd edition. Philadelphia: Lea & Febiger; 1993. Chap 3, p 698.
54. Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med 1995;99:276-281.
55. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE, Willett WC. Multivitamin use, folate, and colon cancer for women in the Nurses' Health Study. Ann Intern Med 1998; 129:517-524.